Komamura Kazuo
Cardiovascular Division, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.
Cardiol Res Pract. 2013;2013:824135. doi: 10.1155/2013/824135. Epub 2013 Dec 29.
Pathophysiology of heart failure has been considered to be a damaged state of systolic function of the heart followed by a state of low cardiac output that is, systolic heart failure. Even if systolic function is preserved, left ventricular filling in diastole can be impeded and resulted in elevation of filling pressure and symptoms of heart failure. This kind of heart failure is called diastolic heart failure. Nowadays, diastolic heart failure is referred to as heart failure with preserved ejection fraction (HFpEF), whereas systolic heart failure is referred to as heart failure with reduced ejection fraction (HFrEF). In this paper, the similarities and differences between the pathogenesis and pathophysiology of diastolic and systolic heart failure were reviewed. Although diastolic heart failure is a common condition of heart failure worldwide, its pathophysiology has not been sufficiently elucidated. This is thought to be the most significant reason for a lack of established treatment methods for diastolic heart failure. We hope to proceed with future studies on this topic.
心力衰竭的病理生理学一直被认为是心脏收缩功能受损的状态,继而出现心输出量降低的状态,即收缩性心力衰竭。即使收缩功能得以保留,左心室舒张期充盈仍可能受阻,导致充盈压升高和心力衰竭症状。这种心力衰竭称为舒张性心力衰竭。如今,舒张性心力衰竭被称为射血分数保留的心力衰竭(HFpEF),而收缩性心力衰竭被称为射血分数降低的心力衰竭(HFrEF)。本文综述了舒张性和收缩性心力衰竭发病机制与病理生理学之间的异同。尽管舒张性心力衰竭是全球范围内常见的心力衰竭类型,但其病理生理学尚未得到充分阐明。这被认为是舒张性心力衰竭缺乏成熟治疗方法的最重要原因。我们希望就此主题开展未来研究。